5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 49.86▼ | 49.93▼ | 49.88▼ | 48.56▲ | 48.47▲ |
MA10 | 49.91▼ | 49.88▼ | 49.59▲ | 47.94▲ | 48.46▲ |
MA20 | 49.95▼ | 49.53▲ | 49.17▲ | 48.36▲ | 50.01▼ |
MA50 | 49.90▼ | 48.82▲ | 48.11▲ | 48.63▲ | 51.84▼ |
MA100 | 49.66▲ | 47.98▲ | 47.86▲ | 50.43▼ | 50.62▼ |
MA200 | 49.19▲ | 47.98▲ | 48.37▲ | 51.15▼ | 50.19▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.026▼ | -0.017▼ | 0.042▲ | 0.231▲ | -0.142▼ |
RSI | 27.804▼ | 65.909▲ | 73.689▲ | 57.338▲ | 48.666▼ |
STOCH | 3.515▼ | 77.712 | 90.785▲ | 81.364▲ | 40.886 |
WILL %R | -100.000▼ | -26.540 | -15.512▲ | -5.085▲ | -41.599 |
CCI | -218.280▼ | 18.961 | 65.037 | 136.405▲ | -11.654 |
Thursday, August 14, 2025 01:39 AM
Data from the positive Phase 2 study evaluating rilzabrutinib for the treatment of IgG4-related disease presented at EULAR 2025Additional orphan designation underscores Sanofi commitment to advancing ...
|
Tuesday, August 12, 2025 07:04 AM
Sanofi (NASDAQ:SNY) has stopped shipping its anti-cholesterol therapy Praluent, developed with Regeneron (NASDAQ:REGN), as surging demand has caused availability issues, Reuters reported on Tuesday, ...
|
Tuesday, August 12, 2025 03:50 AM
Sanofi (NASDAQ:SNY) announced on Tuesday that it has stopped supplying Praluent in China due to limited availability of the popular cholesterol medication.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 49.58 | 50.04 | 49.48 | 49.77 | 2,022,457 |
14/08/25 | 48.34 | 49.065 | 48.23 | 49.04 | 2,462,355 |
13/08/25 | 48.53 | 48.895 | 48.47 | 48.74 | 1,685,807 |
12/08/25 | 47.35 | 48.08 | 47.29 | 48.05 | 1,925,809 |
11/08/25 | 47.27 | 47.55 | 47.07 | 47.21 | 2,771,066 |
08/08/25 | 46.89 | 47.48 | 46.81 | 47.13 | 2,968,334 |
07/08/25 | 46.90 | 47.54 | 46.80 | 47.43 | 3,650,968 |
06/08/25 | 47.29 | 47.47 | 46.1421 | 46.18 | 3,487,401 |
05/08/25 | 47.78 | 47.89 | 47.53 | 47.84 | 2,755,264 |
04/08/25 | 46.83 | 48.07 | 46.82 | 48.05 | 2,951,266 |
|
|
||||
|
|
||||
|
|